Your NEJM Group Today: Paclitaxel-Coated Devices & Mortality / Lyme Disease Guidelines / Pulmonology & Hospital Medicine Opportunities

By the Editors

Here's what's happening across NEJM Group:

New England Journal of Medicine: In a randomized trial among patients with peripheral artery disease, paclitaxel-coated endovascular devices were not associated with increased mortality risk relative to uncoated devices — a finding that contrasts with results from a recent meta-analysis. Researchers speculate on the reasons for the disparate findings.

NEJM Journal Watch: The Infectious Diseases Society of America, the American Academy of Neurology, and the American College of Rheumatology offer updated guidelines on the prevention, diagnosis, and treatment of Lyme disease.

NEJM CareerCenter:

• Pulmonology/critical care: The Department of Internal Medicine at the University of California, UC Davis Health, seeks a successful physician-leader to serve as Chief of the Division of Pulmonary, Critical Care, and Sleep Medicine.

• Hospital medicine: Novant Health in North Carolina is looking for compassionate, caring hospitalist physicians to join its rapidly growing inpatient provider team.